Viking Pharma (VKTX) - Quarterly EPS earnings growth

Public company logo of Viking Therapeutics Corp (VKTX)

Viking Therapeutics (VKTX) is evolving independently of macro cycles, driven by the hype surrounding weight-loss innovations. The quarterly EPS growth vector on the GURU.Markets interface reflects this trend, where the value -92.70 serves as the baseline indicator. The company's prospects are bolstered by the potential of the VK2735 drug and the likelihood of acquisition by industry behemoths, while the diversification of its metabolic portfolio mitigates the risks associated with individual trials.

VKTX: Viking Therapeutics Inc Year-over-year earnings per one share growth for the last 12 months 07/04/2022 - 11/18/2026

Viking Therapeutics (VKTX) - metric breakdowns and financial figures

- market value and analyst target forecast:
Comprehensive company analysis:Viking Therapeutics
Flagship merchandise of Viking Therapeutics Corp

Viking Therapeutics focuses on developing innovative treatments for metabolic disorders, where the success of VK2735 determines the financial trajectory. This metric captures the percentage change in earnings per share compared to the same period last year. It measures the efficiency of capitalizing on clinical achievements and the business's ability to generate real income. It is critical for investors to distinguish a sustainable trend from short-term spikes. By analyzing comparable quarterly EPS growth, one can assess the inflation protection of the investment.

Who Viking Therapeutics competes with

BIIB: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Bioscience Ltd) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Axsome Therapeutics, Inc. AXSM|Year-over-year net earnings per share growth for the last 12 months ACAD (ACADIA Pharmaceuticals Inc.)|XENE: Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Supernus Corp SUPN|Year-over-year earnings per share growth rate for the last twelve months CPRX (Catalyst Pharmaceuticals)|Denali Therapeutics - Quarterly EPS earnings growth|HRMY: Year-over-year earnings per share growth for the last twelve months|Biohaven (BHVN) - Year-over-year earnings per share growth for the last twelve months|Amylyx Pharmaceuticals Inc (AMLX) - Quarterly EPS earnings growth|TRVI (Trevi Therapeutics Inc) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Praxis Medicines (PRAX)|Year-over-year net earnings per share growth for the last 12 months AVXL (Anavex Life Sciences)|Year-over-year net earnings per share growth for the last 12 months CeriBell CBLL|Year-over-year earnings per share growth for the last twelve months Prothena Biosciences PRTA|Quarterly EPS earnings growth Alector, Inc. ALEC|ANNX - Year-over-year earnings per share growth for the last twelve months|OMER - Quarterly EPS earnings growth|Neurogene (NGNE) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months AC Immune SA (ACIU)|Year-over-year net earnings per share growth for the last 12 months VYGR|Quarterly EPS earnings growth Neumora Therapeutics Inc|Year-over-year earnings per share growth for the last twelve months scilexholding.com (SCLX)|Year-over-year net earnings per share change for the last twelve months Tevogen Bio Inc.|Year-over-year earnings per share growth for the last twelve months Alpha Cognition Inc. ACOG|Quarterly EPS earnings growth Cognition Therapeutics CGTX|IKT: Year-over-year net earnings per share growth for the last 12 months|SAVA (Cassava Sciences) - Year-over-year earnings per share growth for the last 12 months|Assertio Holdings, Inc. (ASRT) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months COYA|Year-over-year earnings per share growth for the last twelve months Vistagen|Year-over-year net earnings per share growth for the last 12 months Ovid Therapeutics (OVID)|Year-over-year earnings per share growth for the last twelve months Acumen Pharmaceuticals Inc. (ABOS)|CRVO - Earnings per share growth in annualized terms for the last twelve months|Alterity Therapeutics Limited - Year-over-year net earnings per share growth for the last 12 months|CLNN: Year-over-year earnings per share growth for the last 12 months|pepgen.com - Quarterly EPS earnings growth|JUNS (Jupiter Neurosciences) - Year-over-year earnings per share growth for the last 12 months|Relmada (RLMD) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Annovis Bio (ANVS)|GRCE (gracetx.com) - Quarterly EPS earnings growth|Firefly Neuroscience Inc (AIFF) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months KLTO (Klotho Neurosciences Inc)|NeuroSense Therapeutics Ltd - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth RVPH (Reviva Pharmaceuticals, Inc.)|Year-over-year earnings per one share growth for the last 12 months MTVA|NeurAxis Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Helius Medical Technologies, Inc. HSDT|PASG: Quarterly EPS earnings growth|Neuphoria (NEUP) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Minerva Neurosciences Inc|Athira Pharma Inc (ATHA) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months ADXN (Addex Therapeutics)|Quarterly EPS earnings growth Alzamend Neuro Inc. (ALZN)|Cyclerion Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|PTIX (Protagenic Therapeutics) - Year-over-year net earnings per share trend for the last twelve months|Pasithea Therapeutics Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Cortigent CRGT|ATXI (Avenue Therapeutics, Inc) - Year-over-year net earnings per share growth for the last 12 months|Brainstorm Cell Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months CARA|Earnings per share growth in annualized terms for the last twelve months chromocell.com CHRO|Year-over-year earnings per share growth for the last twelve months Eliem Therapeutics, Inc. (ELYM)|ITCI (Intra-Cellular Therapies, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth LBPH (Longboard Pharmaceuticals Inc)|Quarterly EPS earnings growth Marinus Pharma MRNS|nkgenbiotech.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months NeuroBo Pharmaceuticals, Inc.|Sage Therapeutics (SAGE) - Year-over-year earnings per share growth for the last twelve months|SNPX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Trevena, Inc|Vigil Neuroscience (VIGL) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth WENA|Quarterly EPS earnings growth cerevel.com (CERE)